Literature DB >> 11779697

Cellular signaling pathways engaged by the Epstein-Barr virus transforming protein LMP1.

Eudoxia Hatzivassiliou1, George Mosialos.   

Abstract

The latent membrane protein 1 (LMP1) of Epstein-Barr virus (EBV) is an essential component of the viral machinery that orchestrates cellular transformation and oncogenesis. The critical role of LMP1 in transformation has been established through recombinant genetic analysis of the EBV genome, ectopic expression in cell lines and transgenic mice and immunohistochemical analysis of EBV- associated tumor specimens. The principal mechanism of LMP1 function is based on mimicry of activated cell surface receptors of the tumor necrosis factor superfamily. LMP1 signaling culminates in the activation of transcription factors NF-kappaB, AP1 and STAT1/3, which have been tightly linked to prevention of apoptosis and malignant transformation. The molecular mechanisms of LMP1 function will be reviewed in this report.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11779697     DOI: 10.2741/hatziva

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  21 in total

1.  Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo.

Authors:  Dimitris Panagopoulos; Panayiotis Victoratos; Maria Alexiou; George Kollias; George Mosialos
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 2.  Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.

Authors:  Lingyun Geng; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 3.  Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis.

Authors:  Javier S Burgos
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

4.  Proteome analysis of the transformation potential of the Epstein-Barr virus-encoded latent membrane protein 1 in nasopharyngeal epithelial cells NP69.

Authors:  Qiong Zhang; Zhiwei Zhang; Chengkun Wang; Zhiqiang Xiao; Yanhui Yu; Fang Yang; Zhuchu Chen; Zhimin He
Journal:  Mol Cell Biochem       Date:  2008-04-19       Impact factor: 3.396

5.  Epstein-Barr virus latent membrane protein 1 is not associated with vessel density nor with hypoxia inducible factor 1 alpha expression in nasopharyngeal carcinoma tissue.

Authors:  Alexander A Benders; Weihua Tang; Jaap M Middeldorp; Astrid E Greijer; Leigh B Thorne; William K Funkhouser; W Kimryn Rathmell; Margaret L Gulley
Journal:  Head Neck Pathol       Date:  2009-11-12

6.  Induction of apoptosis by rewiring the signal transduction of Epstein-Barr virus oncoprotein LMP1 toward caspase activation.

Authors:  Eudoxia G Hatzivassiliou; Theodore Tsichritzis; George Mosialos
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

7.  Inhibition of hepatocyte nuclear factor 4 transcriptional activity by the nuclear factor kappaB pathway.

Authors:  Varvara Nikolaidou-Neokosmidou; Vassilis I Zannis; Dimitris Kardassis
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

8.  KSHV LANA and EBV LMP1 induce the expression of UCH-L1 following viral transformation.

Authors:  Gretchen L Bentz; Anjali Bheda-Malge; Ling Wang; Julia Shackelford; Blossom Damania; Joseph S Pagano
Journal:  Virology       Date:  2013-11-08       Impact factor: 3.616

9.  Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity.

Authors:  Mark Rovedo; Richard Longnecker
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

10.  Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1.

Authors:  Do Nguyen-Van; Ingemar Ernberg; Ingemar Enrberg; Phi Phan-Thi Phi; Chinh Tran-Thi; LiFu Hu
Journal:  Virus Genes       Date:  2008-07-29       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.